CWA
AVNS

Clarus Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Clarus Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-905
Closed -$39K – 172
2019
Q2 		$39K Hold
905
– – 0.03% 297
2019
Q1 		$39K Hold
905
– – 0.03% 333
2018
Q4 		$41K Hold
905
– – 0.06% 290
2018
Q3 		$62K Hold
905
– – 0.04% 263
2018
Q2 		$42K Buy
+905
New +$47.8K 0.03% 309

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clarus Wealth Advisors's AVNS Position: Q3 2019 in Review

Clarus Wealth Advisors sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 905 shares — an estimated $39K sold.

Clarus Wealth Advisors first reported a position in AVNS in Q2 2018 and held it in 5 quarters. The position peaked at $62K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Clarus Wealth Advisors reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Clarus Wealth Advisors sold 905 Avanos Medical shares in Q3 2019, an estimated $39K.
  • Clarus Wealth Advisors first reported a position in Avanos Medical in Q2 2018 and held it in 5 quarters.
  • Clarus Wealth Advisors's Avanos Medical position peaked at $62K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Clarus Wealth Advisors's 13F filing for Q3 2019, filed 11 Oct 2019.